Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Madrigal Pharmaceuticals Total Liabilities 2010-2024 | MDGL

Madrigal Pharmaceuticals total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Madrigal Pharmaceuticals total liabilities for the quarter ending March 31, 2024 were $0.232B, a 26.99% increase year-over-year.
  • Madrigal Pharmaceuticals total liabilities for 2023 were $0.235B, a 42.4% increase from 2022.
  • Madrigal Pharmaceuticals total liabilities for 2022 were $0.165B, a 113.9% increase from 2021.
  • Madrigal Pharmaceuticals total liabilities for 2021 were $0.077B, a 64.22% increase from 2020.
  
Madrigal Pharmaceuticals Annual Total Liabilities
(Millions of US $)
2023 $235
2022 $165
2021 $77
2020 $47
2019 $25
2018 $8
2017 $10
2016 $5
2015 $49
2014 $36
2013 $46
2012 $28
2011 $28
2010 $31
2009 $24
Madrigal Pharmaceuticals Quarterly Total Liabilities
(Millions of US $)
2024-03-31 $232
2023-12-31 $235
2023-09-30 $216
2023-06-30 $199
2023-03-31 $182
2022-12-31 $165
2022-09-30 $148
2022-06-30 $133
2022-03-31 $77
2021-12-31 $77
2021-09-30 $70
2021-06-30 $57
2021-03-31 $49
2020-12-31 $47
2020-09-30 $50
2020-06-30 $45
2020-03-31 $26
2019-12-31 $25
2019-09-30 $16
2019-06-30 $13
2019-03-31 $11
2018-12-31 $8
2018-09-30 $7
2018-06-30 $5
2018-03-31 $6
2017-12-31 $10
2017-09-30 $9
2017-06-30 $6
2017-03-31 $6
2016-12-31 $5
2016-09-30 $4
2016-06-30 $3
2016-03-31 $9
2015-12-31 $49
2015-09-30 $31
2015-06-30 $33
2015-03-31 $33
2014-12-31 $36
2014-09-30 $40
2014-06-30 $42
2014-03-31 $44
2013-12-31 $46
2013-09-30 $42
2013-06-30 $38
2013-03-31 $37
2012-12-31 $28
2012-09-30 $25
2012-06-30 $27
2012-03-31 $26
2011-12-31 $28
2011-09-30 $29
2011-06-30 $29
2011-03-31 $30
2010-12-31 $31
2010-09-30 $32
2010-06-30 $17
2010-03-31 $19
2009-12-31 $24
2009-09-30 $27
2009-06-30 $157
2009-03-31 $173
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.005B $0.000B
Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-? agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-? agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.981B 31.71
Chugai Pharmaceutical (CHGCY) Japan $49.415B 22.09
Takeda Pharmaceutical (TAK) Japan $41.206B 8.35
Merck (MKGAF) Germany $24.305B 23.57
Astellas Pharma (ALPMY) Japan $17.843B 28.17
Sandoz Group AG (SDZNY) Switzerland $15.171B 0.00
Neurocrine Biosciences (NBIX) United States $14.141B 38.71
Shionogi (SGIOY) Japan $12.740B 11.07
United Therapeutics (UTHR) United States $12.264B 13.07
Catalent (CTLT) United States $9.891B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.585B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.552B 7.20
Revolution Medicines (RVMD) United States $6.291B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.547B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.835B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.064B 0.00
Summit Therapeutics (SMMT) United States $3.033B 0.00
Corcept Therapeutics (CORT) United States $2.898B 26.26
PTC Therapeutics (PTCT) United States $2.848B 0.00
Dyne Therapeutics (DYN) United States $2.731B 0.00
Indivior (INDV) United States $2.305B 10.93
Recursion Pharmaceuticals (RXRX) United States $2.146B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.988B 11.30
Catalyst Pharmaceuticals (CPRX) United States $1.880B 18.30
Fusion Pharmaceuticals (FUSN) Canada $1.829B 0.00
Evotec AG (EVO) Germany $1.747B 0.00
Ardelyx (ARDX) United States $1.731B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.719B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.607B 24.15
Avadel Pharmaceuticals (AVDL) Ireland $1.501B 0.00
Xencor (XNCR) United States $1.464B 0.00
Pacira BioSciences (PCRX) United States $1.411B 13.42
Soleno Therapeutics (SLNO) United States $1.376B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.306B 0.00
4D Molecular Therapeutics (FDMT) United States $1.300B 0.00
Collegium Pharmaceutical (COLL) United States $1.106B 6.62
Enliven Therapeutics (ELVN) United States $1.081B 0.00
Cassava Sciences (SAVA) United States $1.046B 0.00
Cronos Group (CRON) Canada $1.009B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.949B 14.78
Relay Therapeutics (RLAY) United States $0.927B 0.00
USANA Health Sciences (USNA) United States $0.911B 14.90
Ocular Therapeutix (OCUL) United States $0.898B 0.00
ARS Pharmaceuticals (SPRY) United States $0.853B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.839B 0.00
ProKidney (PROK) United States $0.805B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.748B 0.00
Lyell Immunopharma (LYEL) United States $0.691B 0.00
Sage Therapeutics (SAGE) United States $0.681B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.678B 0.00
Silence Therapeutics (SLN) United Kingdom $0.658B 0.00
Harrow (HROW) United States $0.619B 0.00
Savara (SVRA) United States $0.576B 0.00
Exscientia (EXAI) United Kingdom $0.572B 0.00
Siga Technologies (SIGA) United States $0.530B 6.77
Altimmune (ALT) United States $0.524B 0.00
Heron Therapeutics (HRTX) United States $0.523B 0.00
Lexeo Therapeutics (LXEO) United States $0.510B 0.00
OmniAb (OABI) United States $0.505B 0.00
Bioventus (BVS) United States $0.501B 19.18
Larimar Therapeutics (LRMR) United States $0.477B 0.00
KalVista Pharmaceuticals (KALV) United States $0.476B 0.00
Verve Therapeutics (VERV) United States $0.448B 0.00
Korro Bio (KRRO) United States $0.446B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.442B 0.00
Esperion Therapeutics (ESPR) United States $0.426B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.416B 0.00
Fractyl Health (GUTS) United States $0.362B 0.00
Organogenesis (ORGO) United States $0.357B 67.25
Verrica Pharmaceuticals (VRCA) United States $0.354B 0.00
Tourmaline Bio (TRML) United States $0.350B 0.00
Nanobiotix S.A (NBTX) France $0.312B 0.00
Nektar Therapeutics (NKTR) United States $0.305B 0.00
Xeris Biopharma Holdings (XERS) United States $0.289B 0.00
Nature's Sunshine Products (NATR) United States $0.288B 18.33
Aquestive Therapeutics (AQST) United States $0.279B 0.00
ESSA Pharma (EPIX) Canada $0.279B 0.00
Black Diamond Therapeutics (BDTX) United States $0.267B 0.00
Century Therapeutics (IPSC) United States $0.258B 0.00
Foghorn Therapeutics (FHTX) United States $0.256B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.256B 0.00
Acrivon Therapeutics (ACRV) United States $0.250B 0.00
Metagenomi (MGX) United States $0.249B 0.00
CytoDyn (CYDY) United States $0.235B 0.00
Akebia Therapeutics (AKBA) United States $0.228B 0.00
Aldeyra Therapeutics (ALDX) United States $0.225B 0.00
Pyxis Oncology (PYXS) United States $0.225B 0.00
Prelude Therapeutics (PRLD) United States $0.222B 0.00
Conduit Pharmaceuticals (CDT) United States $0.219B 0.00
Eliem Therapeutics (ELYM) United States $0.216B 0.00
Avita Medical (RCEL) United States $0.212B 0.00
Galectin Therapeutics (GALT) United States $0.190B 0.00
Zevra Therapeutics (ZVRA) United States $0.188B 0.00
Adherex Technologies (FENC) United States $0.188B 229.00
Telomir Pharmaceuticals (TELO) United States $0.187B 0.00
Achieve Life Sciences (ACHV) Canada $0.186B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
Elite Pharmaceuticals (ELTP) United States $0.181B 16.90
Innate Pharma SA (IPHYF) France $0.176B 0.00
Incannex Healthcare (IXHL) Australia $0.171B 0.00
MediWound (MDWD) Israel $0.161B 0.00
VAXART, INC (VXRT) United States $0.159B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.158B 0.00
Cardiol Therapeutics (CRDL) Canada $0.152B 0.00
Context Therapeutics (CNTX) United States $0.146B 0.00
Karyopharm Therapeutics (KPTI) United States $0.128B 0.00
OptiNose (OPTN) United States $0.128B 0.00
FibroGen (FGEN) United States $0.127B 0.00
Regulus Therapeutics (RGLS) United States $0.126B 0.00
Citius Pharmaceuticals (CTXR) United States $0.124B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.121B 8.09
PMV Pharmaceuticals (PMVP) United States $0.104B 0.00
ProPhase Labs (PRPH) United States $0.102B 0.00
Assertio Holdings (ASRT) United States $0.096B 4.39
Relmada Therapeutics (RLMD) United States $0.094B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
AlloVir (ALVR) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
SCYNEXIS (SCYX) United States $0.085B 1.19
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.071B 0.00
Tempest Therapeutics (TPST) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.063B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
Protara Therapeutics (TARA) United States $0.057B 0.00
Carisma Therapeutics (CARM) United States $0.052B 0.00
Nutriband (NTRB) United States $0.052B 0.00
Inotiv (NOTV) United States $0.051B 0.00
BioLineRx (BLRX) Israel $0.048B 0.00
Gain Therapeutics (GANX) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.043B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
DURECT (DRRX) United States $0.039B 0.00
NRx Pharmaceuticals (NRXP) United States $0.039B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
VYNE Therapeutics (VYNE) United States $0.038B 0.00
Unicycive Therapeutics (UNCY) United States $0.036B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
Lipocine (LPCN) United States $0.035B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.029B 0.00
BioVie (BIVI) United States $0.028B 0.00
JanOne (JAN) United States $0.027B 0.00
Oncternal Therapeutics (ONCT) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.023B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.021B 0.80
Aptorum Group (APM) United Kingdom $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
Lyra Therapeutics (LYRA) United States $0.020B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Alaunos Therapeutics (TCRT) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Mannatech (MTEX) United States $0.014B 0.00
CERo Therapeutics Holdings (CERO) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Mangoceuticals (MGRX) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
SHINECO (SISI) China $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.02
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 34.15